These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11317167)

  • 21. Phosphorylation of enkephalins enhances their proteolytic stability.
    Dass C; Mahalakshmi P
    Life Sci; 1996; 58(13):1039-45. PubMed ID: 8622556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin.
    Bernkop-Schnürch A; Obermair K; Greimel A; Palmberger TF
    Amino Acids; 2006 Jun; 30(4):417-23. PubMed ID: 16554973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
    Gillespie MN; Krechniak JW; Crooks PA; Altiere RJ; Olson JW
    J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative.
    Hussain MA; Rowe SM; Shenvi AB; Aungst BJ
    Drug Metab Dispos; 1990; 18(3):288-91. PubMed ID: 2143133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
    Bausback HH; Ward PE
    Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transport kinetics of leucine enkephalin across Caco-2 monolayers: quantitative analysis for contribution of enzymatic and transport barrier.
    Quan YS; Fujita T; Tohara D; Tsuji M; Kohyama M; Yamamoto A
    Life Sci; 1999; 64(14):1243-52. PubMed ID: 10210267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymes and inhibitors in leu-enkephalin in metabolism in human plasma.
    Bolacchi F; Marini M; Urbani A; Roda LG
    Neurochem Res; 1995 Sep; 20(9):991-9. PubMed ID: 8570020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new aminopeptidase in monkey cerebral membrane fraction: hydrolysis of enkephalin.
    Shimamura M; Hazato T; Iwaguchi T
    Brain Res; 1988 Apr; 445(2):350-3. PubMed ID: 3370467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of enkephalin by brain enzymes.
    Vogel Z; Altstein M
    Prog Biochem Pharmacol; 1980; 16():49-59. PubMed ID: 7003599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of an enkephalin-degrading aminopeptidase from guinea pig serum.
    Shimamura M; Hazato T; Katayama T
    Biochim Biophys Acta; 1984 Mar; 798(1):8-13. PubMed ID: 6367829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma.
    Welch RM; Brown A; Ravitch J; Dahl R
    Clin Pharmacol Ther; 1995 Aug; 58(2):132-42. PubMed ID: 7648763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B; Gros C; Solhonne B; Schwartz JC
    Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a phase I clinical trial.
    de Jong J; Geijssen GJ; Munniksma CN; Vermorken JB; van der Vijgh WJ
    J Clin Oncol; 1992 Dec; 10(12):1897-906. PubMed ID: 1453205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of leu-enkephalin hydrolysis in human plasma.
    Roscetti G; Possenti R; Bassano E; Roda LG
    Neurochem Res; 1985 Oct; 10(10):1393-404. PubMed ID: 3906420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bioavailability of dalargin and its metabolism during intranasal administration to rats].
    Vinogradov VA; Kalenikova EI; Sokolov AS
    Biull Eksp Biol Med; 1988 Jul; 106(7):48-50. PubMed ID: 3401577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
    Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
    Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical and enzymatic stability as well as transport properties of a Leu-enkephalin analogue and ester prodrugs thereof.
    Fredholt K; Adrian C; Just L; Hoj Larsen D; Weng S; Moss B; Juel Friis G
    J Control Release; 2000 Feb; 63(3):261-73. PubMed ID: 10601722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Leu-enkephalin homogeneously labeled with tritium in studying the Selank inhibiting effect on the enkephalin-degrading enzymes of human plasma].
    Zolotarev IuA; Sokolov OIu; Kost NV; Vas'kovskiĭ BV; Miasoedov NF; Zozulia AA
    Bioorg Khim; 2004; 30(3):234-40. PubMed ID: 15344652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of human nasal primary culture systems to investigate peptide metabolism.
    Hoang VD; Uchenna AR; Mark J; Renaat K; Norbert V
    Int J Pharm; 2002 May; 238(1-2):247-56. PubMed ID: 11996828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of glycation on the chemical and enzymatic stability of the endogenous opioid peptide, leucine-enkephalin, and related fragments.
    Jakas A; Horvat S
    Bioorg Chem; 2004 Dec; 32(6):516-26. PubMed ID: 15530992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.